11.30
+0.18(+1.62%)
Currency In USD
Address
300 Connell Drive
Berkeley Heights, NJ 07922
United States of America
Phone
908 517 9500
Website
Sector
Healthcare
Industry
Biotechnology
Employees
64
First IPO Date
May 13, 2010
| Name | Title | Pay | Year Born |
| Mr. Joseph Todisco MBA | Chief Executive Officer & Director | 1.15M | 1976 |
| Ms. Erin Mistry | Executive Vice President & Chief Commercial Officer | 561,571 | 1982 |
| Dr. Matthew T. David M.D. | Executive Vice President & Chief Financial Officer | 634,855 | 1978 |
| Ms. Elizabeth Masson-Hurlburt B.A. | Executive Vice President and Chief Clinical Strategy & Operations Officer | 682,195 | 1979 |
| Dr. Tushar Mukherjee | Senior Vice President & Head of Technical Operations | 0 | N/A |
| Donna Ucci | Senior Vice President & Head of Global Quality | 0 | N/A |
| Ms. Kaufman Beth Zelnick Esq. | EVice President, Chief Legal, Compliance Officer & Corporate Secretary | 0 | 1961 |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.